Equities analysts expect Agilent Technologies Inc (NYSE:A) to post $0.58 earnings per share for the current quarter, according to Zacks Investment Research. Seven analysts have made estimates for Agilent Technologies’ earnings, with the highest EPS estimate coming in at $0.62 and the lowest estimate coming in at $0.57. Agilent Technologies reported earnings of $0.53 per share during the same quarter last year, which suggests a positive year over year growth rate of 9.4%. The business is expected to report its next quarterly earnings report after the market closes on Wednesday, February 14th.
On average, analysts expect that Agilent Technologies will report full-year earnings of $2.58 per share for the current year, with EPS estimates ranging from $2.54 to $2.68. For the next fiscal year, analysts forecast that the firm will post earnings of $2.88 per share, with EPS estimates ranging from $2.77 to $2.97. Zacks’ EPS calculations are an average based on a survey of sell-side research analysts that follow Agilent Technologies.
Agilent Technologies (NYSE:A) last released its quarterly earnings results on Monday, November 20th. The medical research company reported $0.67 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.62 by $0.05. The business had revenue of $1.19 billion during the quarter, compared to analyst estimates of $1.17 billion. Agilent Technologies had a net margin of 15.30% and a return on equity of 16.95%. The business’s revenue was up 7.0% on a year-over-year basis. During the same period last year, the business earned $0.59 EPS.
A has been the subject of several recent analyst reports. Robert W. Baird reissued a “buy” rating and set a $70.00 price objective on shares of Agilent Technologies in a report on Friday, October 20th. Zacks Investment Research lowered shares of Agilent Technologies from a “buy” rating to a “hold” rating in a report on Monday, October 30th. Morgan Stanley reaffirmed an “overweight” rating on shares of Agilent Technologies in a report on Tuesday, November 14th. Deutsche Bank set a $75.00 price target on shares of Agilent Technologies and gave the company a “buy” rating in a report on Tuesday, November 21st. Finally, JPMorgan Chase & Co. lifted their price target on shares of Agilent Technologies to $75.00 and gave the company an “overweight” rating in a report on Tuesday, November 21st. Six investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. Agilent Technologies currently has a consensus rating of “Buy” and a consensus target price of $69.25.
In related news, CEO Michael R. Mcmullen sold 21,850 shares of the business’s stock in a transaction that occurred on Monday, January 29th. The shares were sold at an average price of $75.00, for a total value of $1,638,750.00. Following the sale, the chief executive officer now directly owns 324,687 shares in the company, valued at approximately $24,351,525. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Patrick Kaltenbach sold 7,358 shares of the business’s stock in a transaction that occurred on Wednesday, November 22nd. The stock was sold at an average price of $69.28, for a total transaction of $509,762.24. Following the completion of the sale, the insider now owns 72,862 shares in the company, valued at $5,047,879.36. The disclosure for this sale can be found here. Insiders have sold a total of 219,991 shares of company stock worth $15,468,795 over the last 90 days.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. BlackRock Inc. lifted its stake in Agilent Technologies by 8.1% in the fourth quarter. BlackRock Inc. now owns 25,665,358 shares of the medical research company’s stock valued at $1,718,808,000 after acquiring an additional 1,912,186 shares during the last quarter. Arrowstreet Capital Limited Partnership lifted its holdings in shares of Agilent Technologies by 145.4% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 1,726,929 shares of the medical research company’s stock worth $115,652,000 after buying an additional 1,023,099 shares in the last quarter. TimesSquare Capital Management LLC acquired a new stake in shares of Agilent Technologies during the third quarter worth $58,550,000. Janus Henderson Group PLC lifted its holdings in shares of Agilent Technologies by 2,135.0% during the second quarter. Janus Henderson Group PLC now owns 836,051 shares of the medical research company’s stock worth $49,587,000 after buying an additional 798,643 shares in the last quarter. Finally, Bank of Montreal Can lifted its holdings in shares of Agilent Technologies by 187.3% during the fourth quarter. Bank of Montreal Can now owns 742,001 shares of the medical research company’s stock worth $49,693,000 after buying an additional 483,721 shares in the last quarter.
Shares of Agilent Technologies (NYSE:A) traded up $1.96 during mid-day trading on Friday, reaching $68.94. 1,586,046 shares of the company’s stock traded hands, compared to its average volume of 2,129,826. The firm has a market cap of $21,615.61, a price-to-earnings ratio of 32.70, a P/E/G ratio of 2.02 and a beta of 1.28. The company has a debt-to-equity ratio of 0.37, a quick ratio of 2.85 and a current ratio of 3.30. Agilent Technologies has a 52 week low of $50.09 and a 52 week high of $75.00.
The business also recently declared a quarterly dividend, which was paid on Wednesday, January 24th. Shareholders of record on Tuesday, January 2nd were given a dividend of $0.149 per share. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.86%. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.13. The ex-dividend date of this dividend was Friday, December 29th. Agilent Technologies’s payout ratio is 28.57%.
TRADEMARK VIOLATION WARNING: “$0.58 Earnings Per Share Expected for Agilent Technologies Inc (A) This Quarter” was originally posted by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are accessing this piece on another publication, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece can be viewed at https://www.thelincolnianonline.com/2018/02/19/0-58-earnings-per-share-expected-for-agilent-technologies-inc-a-this-quarter-updated.html.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.